SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-059792
Filing Date
2019-11-05
Accepted
2019-11-05 06:33:48
Documents
3
Period of Report
2019-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-21894_18k.htm 8-K 31838
2 EX-99.1 a19-21894_1ex99d1.htm EX-99.1 23119
3 GRAPHIC g218941mmi001.jpg GRAPHIC 3163
  Complete submission text file 0001104659-19-059792.txt   60882
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 191191667
SIC: 2834 Pharmaceutical Preparations